Procurement Summary
Country: USA
Summary: Dow Alzheimer-S Transforming Diagnosis Award
Deadline: 24 Sep 2026
Posting Date: 02 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140550750
Document Ref. No.: HT942526AZRPTRDA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Alzheimer-S Research Program (Azrp) Transforming Diagnosis Award (Trda) Supports Non-Incremental, Solutions-Oriented Research That Reduces Or Overcomes Important Barriers To Obtaining A Diagnosis, Meaningful Disease Monitoring And Accurate Prognosis.Distinctive Features:Clinical Research Is Allowed, However Clinical Trials And Animal Research Are Prohibited. Preliminary Data Are Required.Community Collaboration Is Required For Studies Prospectively Enrolling Human Subjects.Study Population: The Azrp Encourages Studies To Leverage Existing Cohorts/Datasets. Cohorts Consisting Of Individuals 65 Years Or Younger Are Also Encouraged.Career Initiation Or Transition (Cit) Partnership Option: The Trda Includes An Option For More Than One Pi And Supports Both New And Existing Collaborative Partnerships. If Recommended For Funding, Each Pi Will Be Named On Separate Awards To The Recipient Organization(S). If Utilizing This Option, At Least One Independent Investigator Must Meet The Cit Partnership Option Eligibility Requirements At The Time Of Application Submission.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Azrp Trda Program Announcementmay 1, 2026 07:44 Pm Utclink To Additional Information--Closing: September 24, 2026
Posted Date: 2026-05-01 00:00:00
Funding instrument type: Grant
Documents
Tender Notice